ExitedHealthcarePortfolioVenture Incubator


Endoart Logo

EndoArt develops and markets telemetrically driven implantable, batterie-less devices for unmet medical conditions. The company’s main activity is on the treatment of morbid obesity using a remotely controlled gastric band based on its proprietary FloWatch® technology (FloWatch®-TGB, EASYBAND®).

Endoart has been acquired in 2007 by Allergan for USD 97m.